Hypoxia inducible factor‐1 alpha plays a pivotal role in hepatic metastasis of pancreatic cancer: an immunohistochemical study. Issue 2 (20th June 2013)
- Record Type:
- Journal Article
- Title:
- Hypoxia inducible factor‐1 alpha plays a pivotal role in hepatic metastasis of pancreatic cancer: an immunohistochemical study. Issue 2 (20th June 2013)
- Main Title:
- Hypoxia inducible factor‐1 alpha plays a pivotal role in hepatic metastasis of pancreatic cancer: an immunohistochemical study
- Authors:
- Matsuo, Yoichiro
Ding, Qiang
Desaki, Ryosuke
Maemura, Kosei
Mataki, Yuko
Shinchi, Hiroyuki
Natsugoe, Shoji
Takao, Sonshin - Abstract:
- <abstract abstract-type="main"> <title>Abstract</title> <sec id="jhbp6-sec-0001" sec-type="section"> <title>Background</title> <p>Hypoxia is an important condition to promote angiogenesis that is essential to tumor progression, including pancreatic ductal adenocarcinoma (PDAC). We evaluated whether the immunohistochemistry for hypoxia inducible factor‐1α (HIF‐1α) was correlated with hepatic metastases in PDAC.</p> </sec> <sec id="jhbp6-sec-0002" sec-type="section"> <title>Methods</title> <p>We examined the expression of HIF‐1α, vascular endothelial growth factor‐A (VEGF‐A), thymidine phosphorylase (TP) and basic fibroblast growth factor (bFGF) in a total of 100 paraffin‐embedded PDAC primary tumors using immunohistochemical staining, and assessed their clinicopathological correlations. We determined microvessel count (MVC) and apoptotic index (AI), and assessed their correlations with hepatic metastases. Student's <italic>t</italic>‐test, the Mann–Whitney <italic>U</italic>‐test, and Spearman correlation coefficients were used to validate the model, and regression analysis was used to test the model.</p> </sec> <sec id="jhbp6-sec-0003" sec-type="section"> <title>Results</title> <p>Hypoxia inducible factor‐1α expression induced the expression of multiple angiogenic factors, leading to a higher MVC and a lower AI. HIF‐1α expression (<italic>P</italic> = 0.0087) and angiogenic factors (<italic>P</italic> = 0.0079) were significantly associated with not only the microvessel<abstract abstract-type="main"> <title>Abstract</title> <sec id="jhbp6-sec-0001" sec-type="section"> <title>Background</title> <p>Hypoxia is an important condition to promote angiogenesis that is essential to tumor progression, including pancreatic ductal adenocarcinoma (PDAC). We evaluated whether the immunohistochemistry for hypoxia inducible factor‐1α (HIF‐1α) was correlated with hepatic metastases in PDAC.</p> </sec> <sec id="jhbp6-sec-0002" sec-type="section"> <title>Methods</title> <p>We examined the expression of HIF‐1α, vascular endothelial growth factor‐A (VEGF‐A), thymidine phosphorylase (TP) and basic fibroblast growth factor (bFGF) in a total of 100 paraffin‐embedded PDAC primary tumors using immunohistochemical staining, and assessed their clinicopathological correlations. We determined microvessel count (MVC) and apoptotic index (AI), and assessed their correlations with hepatic metastases. Student's <italic>t</italic>‐test, the Mann–Whitney <italic>U</italic>‐test, and Spearman correlation coefficients were used to validate the model, and regression analysis was used to test the model.</p> </sec> <sec id="jhbp6-sec-0003" sec-type="section"> <title>Results</title> <p>Hypoxia inducible factor‐1α expression induced the expression of multiple angiogenic factors, leading to a higher MVC and a lower AI. HIF‐1α expression (<italic>P</italic> = 0.0087) and angiogenic factors (<italic>P</italic> = 0.0079) were significantly associated with not only the microvessel status (<italic>P</italic> = 0.022) but also the high incidence of hepatic metastasis (<italic>P</italic> = 0.02), resulting in the worse survival of PDAC patients (<italic>P</italic> &lt; 0.05).</p> </sec> <sec id="jhbp6-sec-0004" sec-type="section"> <title>Conclusions</title> <p>Hypoxia inducible factor‐1α plays a pivotal role in hepatic metastasis through its association with the expression of angiogenic factors in PDAC patients. These results may contribute future therapeutic strategies to prevent pancreatic cancer metastasis.</p> </sec> </abstract> … (more)
- Is Part Of:
- Journal of hepato-biliary-pancreatic sciences. Volume 21:Issue 2(2014)
- Journal:
- Journal of hepato-biliary-pancreatic sciences
- Issue:
- Volume 21:Issue 2(2014)
- Issue Display:
- Volume 21, Issue 2 (2014)
- Year:
- 2014
- Volume:
- 21
- Issue:
- 2
- Issue Sort Value:
- 2014-0021-0002-0000
- Page Start:
- 105
- Page End:
- 112
- Publication Date:
- 2013-06-20
- Subjects:
- Liver -- Diseases -- Periodicals
Biliary tract -- Diseases -- Periodicals
Pancreas -- Diseases -- Periodicals
617.556 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1868-6982 ↗
http://www.springerlink.com/content/121581 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/jhbp.6 ↗
- Languages:
- English
- ISSNs:
- 1868-6974
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4997.660000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 3194.xml